PA
Prism Advisors’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,412
| Closed | -$206K | – | 64 |
|
|
2024
Q3 | $206K | Buy |
+1,412
| New | +$206K | 0.06% | 66 |
|
|
2024
Q2 | – | Sell |
-1,517
| Closed | -$208K | – | 66 |
|
|
2024
Q1 | $208K | Sell |
1,517
-30
| -2% | -$4.12K | 0.06% | 56 |
|
|
2023
Q4 | $210K | Buy |
+1,547
| New | +$210K | 0.07% | 63 |
|
|
2023
Q3 | – | Sell |
-1,608
| Closed | -$204K | – | 61 |
|
|
2023
Q2 | $204K | Buy |
+1,608
| New | +$204K | 0.07% | 51 |
|
|
2023
Q1 | – | Sell |
-1,543
| Closed | -$203K | – | 52 |
|
|
2022
Q4 | $203K | Sell |
1,543
-184
| -11% | -$24.2K | 0.07% | 44 |
|
|
2022
Q3 | $202K | Hold |
1,727
| – | – | 0.08% | 50 |
|
|
2022
Q2 | $203K | Buy |
+1,727
| New | +$203K | 0.08% | 48 |
|
|
2021
Q3 | – | Sell |
-1,505
| Closed | -$246K | – | 53 |
|
|
2021
Q2 | $246K | Hold |
1,505
| – | – | 0.09% | 48 |
|
|
2021
Q1 | $227K | Hold |
1,505
| – | – | 0.08% | 45 |
|
|
2020
Q4 | $228K | Hold |
1,505
| – | – | 0.09% | 47 |
|
|
2020
Q3 | $204K | Hold |
1,505
| – | – | 0.09% | 43 |
|
|
2020
Q2 | $206K | Buy |
+1,505
| New | +$206K | 0.09% | 44 |
|
|
2020
Q1 | – | Sell |
-1,772
| Closed | -$214K | – | 59 |
|
|
2019
Q4 | $214K | Buy |
+1,772
| New | +$214K | 0.11% | 63 |
|
|
2018
Q3 | – | Sell |
-1,762
| Closed | -$205K | – | 56 |
|
|
2018
Q2 | $205K | Buy |
+1,762
| New | +$205K | 0.11% | 53 |
|